Cite
HARVARD Citation
Dulloo, S. et al. (n.d.). EGFR tyrosine kinase inhibitors in non-small cell lung cancer (NSCLC) with EGFR activating mutations – real world data. Lung cancer. pp. S40-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Dulloo, S. et al. (n.d.). EGFR tyrosine kinase inhibitors in non-small cell lung cancer (NSCLC) with EGFR activating mutations – real world data. Lung cancer. pp. S40-. [Online].